Who is the lecturer for the JPI seminar scheduled on April 9th, 2026?

The lecturer is Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office at the Ministry of Health, Labour and Welfare.

What is the definition of the drug loss problem mentioned in the lecture overview?

It refers to the problem where medicines approved in Europe and the United States are not developed in Japan.

They aim to strengthen Japan's drug discovery capabilities, deliver medicines rapidly, and sustain the cycle of investment and innovation.

Yes, applications for archive streaming will be accepted even after the seminar has ended.

AI News NQ Analysis

NQ Score 50/100

AI analysis data is not yet available.

Q: Who is the lecturer for the JPI seminar scheduled on April 9th, 2026?: A: The lecturer is Mr. Yasuhiro Araki, Director of the Clinical Trial Promotion Office at the Ministry of Health, Labour and Welfare.
Q: What is the main topic that will be explained in detail during the seminar?: A: The seminar will explain building a drug discovery ecosystem and measures to promote clinical trials in Japan.
Q: What is the definition of the drug loss problem mentioned in the lecture overview?: A: It refers to the problem where medicines approved in Europe and the United States are not developed in Japan.
Q: What are the specific three goals that the public and private sectors in Japan are working together to achieve?: A: They aim to strengthen Japan's drug discovery capabilities, deliver medicines rapidly, and sustain the cycle of investment and innovation.
Q: Is it possible to apply for the archive streaming of the seminar after it has ended?: A: Yes, applications for archive streaming will be accepted even after the seminar has ended.